Molecular Innovations Technology »

Meet Our Newest Members.

Check out our newest members' profiles and browse through the directory to see all our Chamber Members.

Member Directory » Pharmaceuticals » Molecular Innovations Technology

Molecular Innovations Technology

Name: Michael Silver

Title: Michael Silver

Address: 233 Westervelt Lane

Address: Mahwah, NJ 07430

Phone: 8457381519



Industry: Pharmaceuticals

Business Bio: Molecular Innovations Technology (MIT) was founded in March 2015 to answer the unmet needs of (1) many international medical and life science start-ups with promising products, who need the breadth and depth of MIT experience and expertise to expand their new product’s applications, and capabilities; (2) mature companies that wish to expand their product lines into areas outside their core expertise, typically, through acquisitions of other companies, or licensing technology through corporate or academic sources.

Business Description: We provide a complete mentoring, advisory, and hands-on service, identifying strategies and implementation of plans that will expedite the time to market. MIT enters into business relationships that are tailor-made for each client. The Challenge (need) Many inventors and entrepreneurs conceive of creative, ingenious products, and need expertise and experience to help them (1)transform their idea and concept to a practical, marketable design, or (2) provide crucial product testing and application development results to strengthen the product launch into the market. MIT provides comprehensive programs to accomplish these goals. MIT has the resources to serve as distributor of products that are ready for market. Services MIT delivers the following services; 1. Provide analysis of feasibility (validity of the potential product) 2. Identify the best application of the IP 3. Assist in patent writing 4. Provide regulatory path and plan 5. Write product development plan 6. Organize key opinion leader committee 7. Execute validation experiments 8. Write results of experiments as “white papers”, presentations, or submit results for publication in peer-reviewed journals